Is Twist Bioscience Stock a Good Investment?
Twist Bioscience Investment Advice | TWST |
- Examine Twist Bioscience's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Twist Bioscience's leadership team and their track record. Good management can help Twist Bioscience navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Biotechnology space and any emerging trends that could impact Twist Bioscience's business and its evolving consumer preferences.
- Compare Twist Bioscience's performance and market position to its competitors. Analyze how Twist Bioscience is positioned in terms of product offerings, innovation, and market share.
- Check if Twist Bioscience pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Twist Bioscience's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Twist Bioscience Corp stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Twist Bioscience Corp is a good investment.
Sell | Buy |
Strong Sell
Market Performance | Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Hyperactively responds to market trends | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Not Available | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine Twist Bioscience Stock
Researching Twist Bioscience's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 98.0% of the company shares are owned by institutional investors. The book value of Twist Bioscience was at this time reported as 7.35. The company recorded a loss per share of 3.25. Twist Bioscience Corp had not issued any dividends in recent years.
To determine if Twist Bioscience is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Twist Bioscience's research are outlined below:
| Twist Bioscience generated a negative expected return over the last 90 days | |
| Twist Bioscience has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 312.97 M. Net Loss for the year was (208.73 M) with profit before overhead, payroll, taxes, and interest of 162.37 M. | |
| Twist Bioscience Corp currently holds about 504.97 M in cash with (64.09 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 8.93. | |
| Over 98.0% of the company shares are owned by institutional investors | |
| Latest headline from simplywall.st: Breakeven On The Horizon For Glaukos Corporation |
Twist Bioscience uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Twist Bioscience Corp. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Twist Bioscience's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 2nd of February 2024 Upcoming Quarterly Report | View | |
| 3rd of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 15th of November 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 30th of September 2023 Last Financial Announcement | View |
Twist Bioscience's market capitalization trends
The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.11 B.Twist Bioscience's profitablity analysis
The company has Profit Margin (PM) of (0.55) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.45) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.45.Determining Twist Bioscience's profitability involves analyzing its financial statements and using various financial metrics to determine if Twist Bioscience is a good buy. For example, gross profit margin measures Twist Bioscience's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Twist Bioscience's profitability and make more informed investment decisions.
Please note, the imprecision that can be found in Twist Bioscience's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Twist Bioscience Corp. Check Twist Bioscience's Beneish M Score to see the likelihood of Twist Bioscience's management manipulating its earnings.
Basic technical analysis of Twist Stock
As of the 21st of July, Twist Bioscience has the Risk Adjusted Performance of 0.0321, semi deviation of 3.73, and Coefficient Of Variation of 3805.65. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Twist Bioscience Corp, as well as the relationship between them.Twist Bioscience's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Twist Bioscience insiders, such as employees or executives, is commonly permitted as long as it does not rely on Twist Bioscience's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Twist Bioscience insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Twist Bioscience's Outstanding Corporate Bonds
Twist Bioscience issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Twist Bioscience Corp uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Twist bonds can be classified according to their maturity, which is the date when Twist Bioscience Corp has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Understand Twist Bioscience's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Twist Bioscience's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.0321 | |||
| Market Risk Adjusted Performance | (0.11) | |||
| Mean Deviation | 2.95 | |||
| Semi Deviation | 3.73 | |||
| Downside Deviation | 3.92 | |||
| Coefficient Of Variation | 3805.65 | |||
| Standard Deviation | 3.83 | |||
| Variance | 14.65 | |||
| Information Ratio | (0.01) | |||
| Jensen Alpha | 0.1866 | |||
| Total Risk Alpha | (0.45) | |||
| Sortino Ratio | (0.01) | |||
| Treynor Ratio | (0.12) | |||
| Maximum Drawdown | 15.74 | |||
| Value At Risk | (7.89) | |||
| Potential Upside | 6.04 | |||
| Downside Variance | 15.38 | |||
| Semi Variance | 13.92 | |||
| Expected Short fall | (3.30) | |||
| Skewness | (0.37) | |||
| Kurtosis | 0.0283 |
| Risk Adjusted Performance | 0.0321 | |||
| Market Risk Adjusted Performance | (0.11) | |||
| Mean Deviation | 2.95 | |||
| Semi Deviation | 3.73 | |||
| Downside Deviation | 3.92 | |||
| Coefficient Of Variation | 3805.65 | |||
| Standard Deviation | 3.83 | |||
| Variance | 14.65 | |||
| Information Ratio | (0.01) | |||
| Jensen Alpha | 0.1866 | |||
| Total Risk Alpha | (0.45) | |||
| Sortino Ratio | (0.01) | |||
| Treynor Ratio | (0.12) | |||
| Maximum Drawdown | 15.74 | |||
| Value At Risk | (7.89) | |||
| Potential Upside | 6.04 | |||
| Downside Variance | 15.38 | |||
| Semi Variance | 13.92 | |||
| Expected Short fall | (3.30) | |||
| Skewness | (0.37) | |||
| Kurtosis | 0.0283 |
Consider Twist Bioscience's intraday indicators
Twist Bioscience intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Twist Bioscience stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Twist Bioscience time-series forecasting models is one of many Twist Bioscience's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Twist Bioscience's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
Twist Stock media impact
There is far too much social signal, news, headlines, and media speculation about Twist Bioscience that are available to investors today. This information is accessible both publicly - through Twist Bioscience's media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Twist-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Twist Bioscience news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Twist Bioscience relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Twist Bioscience's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Twist Bioscience alpha.
Twist Bioscience Corporate Management
| Dennis JD | Chief VP | Profile | |
| William Banyai | GM Development | Profile | |
| Kevin Yankton | VP Officer | Profile | |
| Chet Gandhi | Chief Officer | Profile | |
| Michael Fero | Chief Officer | Profile |
Additional Tools for Twist Stock Analysis
When running Twist Bioscience's price analysis, check to measure Twist Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Twist Bioscience is operating at the current time. Most of Twist Bioscience's value examination focuses on studying past and present price action to predict the probability of Twist Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Twist Bioscience's price. Additionally, you may evaluate how the addition of Twist Bioscience to your portfolios can decrease your overall portfolio volatility.